Events & Presentations
Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
Feb 4, 2010 at 1:00 PM ET
Registration is required to listen to this webcast.
* Fields Are Required
** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.
|
| Stock Information |
NASDAQ:SPPI
$3.95
+ 0.09
|
Sep 3, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes.
Information provided by eSignal.
| Search Investor Relations |
|
|
